| [1] |
SNYDER MW, KIRCHER M, HILL AJ, et al. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin[J]. Cell, 2016, 164(1/2): 57-68. DOI: 10.1016/j.cell.2015.11.050.
|
| [2] |
CELEC P, VLKOVÁ B, LAUKOVÁ L, et al. Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases[J]. Expert Rev Mol Med, 2018, 20: e1. DOI: 10.1017/erm.2017.12.
|
| [3] |
ALLAM R, KUMAR SV, DARISIPUDI MN, et al. Extracellular histones in tissue injury and inflammation[J]. J Mol Med (Berl), 2014, 92(5): 465-472. DOI: 10.1007/s00109-014-1148-z.
|
| [4] |
ULZ P, HEITZER E, GEIGL JB, et al. Patient monitoring through liquid biopsies using circulating tumor DNA[J]. Int J Cancer, 2017, 141(5): 887-896. DOI: 10.1002/ijc.30759.
|
| [5] |
YU SC, LEE SW, JIANG P, et al. High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing[J]. Clin Chem, 2013, 59(8): 1228-1237. DOI: 10.1373/clinchem.2013.203679.
|
| [6] |
KHIER S, LOHAN L. Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature[J]. Future Sci OA, 2018, 4(4): FSO295. DOI: 10.4155/fsoa-2017-0140.
|
| [7] |
TOSEVSKA A, FRANZKE B, HOFMANN M, et al. Circulating cell-free DNA, telomere length and bilirubin in the vienna active ageing study: exploratory analysis of a randomized, controlled trial[J]. Sci Rep, 2016, 6: 38084. DOI: 10.1038/srep38084.
|
| [8] |
LUCEY MR, TERRAULT N, OJO L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J]. Liver Transpl, 2013, 19(1): 3-26. DOI: 10.1002/lt.23566.
|
| [9] |
MEEUSEN JW, LIESKE JC. Looking for a better creatinine[J]. Clin Chem, 2014, 60(8):1036-1039. DOI: 10.1373/clinchem.2013.220764.
|
| [10] |
LO YM, TEIN MS, PANG CC, et al. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients[J]. Lancet, 1998, 351(9112): 1329-1330. doi: 10.1016/S0140-6736(05)79055-3
|
| [11] |
BECK J, OELLERICH M, SCHULZ U, et al. Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation[J]. Transplant Proc, 2015, 47(8): 2400-2403. DOI: 10.1016/j.transproceed.2015.08.035.
|
| [12] |
GIELIS EM, LEDEGANCK KJ, DE WINTER BY, et al. Cell-free DNA: an upcoming biomarker in transplantation[J]. Am J Transplant, 2015, 15(10): 2541-2551. DOI: 10.1111/ajt.13387.
|
| [13] |
DE VLAMINCK I, MARTIN L, KERTESZ M, et al. Noninvasive monitoring of infection and rejection after lung transplantation[J]. Proc Natl Acad Sci U S A, 2015, 112(43): 13336-13341. DOI: 10.1073/pnas.1517494112.
|
| [14] |
DE VLAMINCK I, VALANTINE HA, SNYDER TM, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection[J]. Sci Transl Med, 2014, 6(241): 241ra77. DOI: 10.1126/scitranslmed.3007803.
|
| [15] |
BECK J, BIERAU S, BALZER S, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury[J]. Clin Chem, 2013, 59(12): 1732-1741. DOI: 10.1373/clinchem.2013.210328.
|
| [16] |
SCHÜTZ E, FISCHER A, BECK J, et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study[J]. PLoS Med, 2017, 14(4): e1002286. DOI: 10.1371/journal.pmed.1002286.
|
| [17] |
SUN K, JIANG P, CHAN KC, et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments[J]. Proc Natl Acad Sci U S A, 2015, 112(40): E5503-E5512. DOI: 10.1073/pnas.1508736112.
|
| [18] |
BLOOM RD, BROMBERG JS, POGGIO ED, et al. Cell-free DNA and active rejection in kidney allografts[J]. J Am Soc Nephrol, 2017, 28(7): 2221-2232. DOI: 10.1681/ASN.2016091034.
|
| [19] |
BROMBERG JS, BRENNAN DC, POGGIO E, et al. Biological variation of donor-derived cell-free DNA in renal transplant recipients: clinical implications[J]. J Appl Lab Med, 2017, 2(3): 309-321. DOI: 10.1373/jalm.2016.022731.
|
| [20] |
OELLERICH M, SCHÜTZ E, KANZOW P, et al. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation[J]. Ther Drug Monit, 2014, 36(2): 136-140. DOI: 10.1097/FTD.0000000000000044.
|
| [21] |
OELLERICH M, WALSON PD, BECK J, et al. Graft-derived cell-free DNA as a marker of transplant graft injury[J]. Ther Drug Monit, 2016, 38(Suppl 1): S75-S79. DOI: 10.1097/FTD.0000000000000239.
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: